2004PubMedRequires access

[The role of cyclooxygenase-2 and vascular endothelial growth factor-C in lymphatic metastasis of gastric cancer].

Jin Liu, Jie‐Ping Yu, Xiao‐Ling Wang, Xiaodong Zhou, Honggang Yu

Open publisher page 4 citations

Abstract

OBJECTIVE: It has been known that cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF)-C are closely related with the development of tumors. To investigate the expression of COX-2 and VEGF-C in gastric cancer and the correlation between them. METHODS: Sixty-four paraffin-embedded gastric cancer samples and 22 flesh gastric cancer samples were tested with using immunohistochemistry method and the reverse transcription-polymerase chain reaction technology respectively. RESULTS: The mean expressive density of COX-2 and VEGF-C mRNA in gastric cancer were both significantly higher than those in non-cancerous gastric mucosa (1.363 +/- 0.351 vs 0.763 +/- 0.304, 0.972 +/- 0.331 vs 0.314 +/- 0.215, P < 0.001). The positive rates of COX-2 and VEGF-C in 64 gastric cancer samples were 72% and 64% respectively. Their expression in the groups of lymph-node metastasis were higher than that of the non-lymph-node metastasis groups respectively (P < 0.05). Moreover, there was a close correlation between COX-2 and VEGF-C expression levels (P < 0.05). CONCLUSIONS: There are high COX-2 and VEGF-C expression in gastric cancer. Gastric tumor tissues that produce VEGF-C may have a higher lymphatic invasion and metastatic potential. COX-2 may participate in VEGF-C lymphangiogenic pathway and the high expression of them may play an important role in the lymphatic proliferation and spread in gastric cancer.

About this research paper

What this paper is about

OBJECTIVE: It has been known that cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF)-C are closely related with the development of tumors. To investigate the expression of COX-2 and VEGF-C in gastric cancer and the correlation between them. METHODS: Sixty-four paraffin-embedded gastric cancer samples and 22 flesh gastric cancer samples were tested with using immunohistochemistry method and the reverse transcription-polymerase chain reaction technology respectively. RESULTS: The mean expressive density of COX-2 and VEGF-C mRNA in gastric cancer were both significantly higher than those in non-cancerous gastric mucosa (1.363 +/- 0.351 vs 0.763 +/- 0.304, 0.972 +/- 0.331 vs 0.314 +/- 0.215, P < 0.001). The positive rates of COX-2 and VEGF-C in 64 gastric cancer samples were 72% and 64% respectively. Their expression in the groups of lymph-node metastasis were higher than that of the non-lymph-node metastasis groups respectively (P < 0.05). Moreover, there was a close correlation between COX-2 and VEGF-C expression levels (P < 0.05). CONCLUSIONS: There are high COX-2 and VEGF-C expression in gastric cancer. Gastric tumor tissues that produce VEGF-C may have a higher lymphatic invasion and metastatic potential. COX-2 may participate in VEGF-C lymphangiogenic pathway and the high expression of them may play an important role in the lymphatic proliferation and spread in gastric cancer.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: It has been known that cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF)-C are closely related with the development of tumors. To investigate the expression of COX-2 and VEGF-C in gastric cancer and the correlation between them. METHODS: Sixty-four paraffin-embedded gastric cancer samples and 22 flesh gastric cancer samples were tested with using immunohistochemistry method and the reverse transcription-polymerase chain reaction technology respectively. RESULTS: The mean expressive density of COX-2 and VEGF-C mRNA in gastric cancer were both significantly higher than those in non-cancerous gastric mucosa (1.363 +/- 0.351 vs 0.763 +/- 0.304, 0.972 +/- 0.331 vs 0.314 +/- 0.215, P < 0.001). The positive rates of COX-2 and VEGF-C in 64 gastric cancer samples were 72% and 64% respectively. Their expression in the groups of lymph-node metastasis were higher than that of the non-lymph-node metastasis groups respectively (P < 0.05). Moreover, there was a close correlation between COX-2 and VEGF-C expression levels (P < 0.05). CONCLUSIONS: There are high COX-2 and VEGF-C expression in gastric cancer. Gastric tumor tissues that produce VEGF-C may have a higher lymphatic invasion and metastatic potential. COX-2 may participate in VEGF-C lymphangiogenic pathway and the high expression of them may play an important role in the lymphatic proliferation and spread in gastric cancer.

Key concepts: Medicine, Vascular endothelial growth factor C, Cancer, Vascular endothelial growth factor, Immunohistochemistry, Lymphatic system, Pathology, Lymphatic vessel

Related papers

Back to paper searchBrowse research topicsOriginal source
[The role of cyclooxygenase-2 and vascular endothelial growth factor-C in lymphatic metastasis of gastric cancer]. — Research Paper | ScholarLens